7,612
edits
Changes
Jump to navigation
Jump to search
**'''Issue: Sales remain the same each year from 2025 to 2030, but patients increase by more than 50% from 12k to 19k.**'''
**'''Issue: Discount rate is negative(!), not taken from the stated source, and entirely wrong!**'''
**'''Issues:**'''
**'''Issue: Students are somewhat double-counted (and their spillovers are quadruple-counted). Their economic benefit (while students) is already contained in the labor spend from operations or the grant income.'''
no edit summary
=== Operations vs. Patients ===
Operations:
=== Discount Rate ===
A discount rate of -0.3% was used, which represents the discount rate recommended by the Office of Management
=== Research funding ===
* Estimating multiplier effects (in-state), especially for non-labor, when there is no in-state activity outside of UVM!
** In particular, there are no externalities to clinical trials or federal grants because there is no one else in the state to benefit from spillovers.
=== Students ===
The spending of these relocated and retained students can be attributed to UVMCC.
